Zevra Therapeutics (ZVRA) Net Cash Flow (2014 - 2026)
Zevra Therapeutics (ZVRA) recorded Net Cash Flow of $50.07 million in Q2 2026, up 415.4% from $9.71 million a year earlier and up 51.9% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Net Cash Flow (2014 - 2026) Analysis & Trends
On a TTM basis, Zevra Therapeutics' Net Cash Flow came in at $97.98 million as of Jun 30, 2026; for FY2025, it was $28.59 million.
- Annual Net Cash Flow has a five-year compound annual growth rate of 106.2% (FY2020 to FY2025).
- Across earlier years, Net Cash Flow came in at -$9.72 million in FY2024, -$22.46 million in FY2023, -$47.08 million in FY2022 and $108.02 million in FY2021.
- The Q2 2026 figure is the highest quarterly Net Cash Flow since Q2 2021.
- Per Business Quant, the preceding three quarters came in at $32.96 million (Q1 2026), $8.29 million (Q4 2025) and $6.66 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -4.43 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -722.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 652.90 Mn |
| 10 | Zevra Therapeutics | 650.98 Mn | -161.73 Mn | 38.18 Mn | 50.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.07 Mn |
| Mar 31, 2026 | 32.96 Mn |
| Dec 31, 2025 | 8.29 Mn |
| Sep 30, 2025 | 6.66 Mn |
| Jun 30, 2025 | 9.71 Mn |
| Mar 31, 2025 | 3.93 Mn |
| Dec 31, 2024 | -20.93 Mn |
| Sep 30, 2024 | 15.27 Mn |
| Jun 30, 2024 | -3.91 Mn |
| Mar 31, 2024 | -155,000.00 |
| Dec 31, 2023 | -569,000.00 |
| Sep 30, 2023 | -22.83 Mn |
| Jun 30, 2023 | 26.28 Mn |
| Mar 31, 2023 | -25.35 Mn |
| Dec 31, 2022 | -4.78 Mn |
| Sep 30, 2022 | -6.74 Mn |
| Jun 30, 2022 | -23.43 Mn |
| Mar 31, 2022 | -12.13 Mn |
| Dec 31, 2021 | -19.16 Mn |
| Sep 30, 2021 | -792,000.00 |
API Access
Zevra Therapeutics Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();